Scarica l'app Stockscreener
469.68
2.99%
-14.47
Dopo l'orario di chiusura:
470.46
0.78
+0.17%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VRTX Giù?
Forum
Previsione
Frazionamento azionario
Vertex Pharmaceuticals Inc Borsa (VRTX) Ultime notizie
Wagner, Vertex Pharmaceuticals evp, sells $4.39m in VRTX stock By Investing.com - Investing.com Nigeria
Why Vertex Pharmaceuticals Incorporated stock could outperform in 2025 - ulpravda.ru
Vertex Pharmaceuticals (VRTX) Stock Falls Amid Market Uptick: What Investors Need to Know - Yahoo Finance
Is Vertex Pharmaceuticals Incorporated stock ready for breakoutPortfolio Risk Report & Daily Growth Stock Investment Tips - ulpravda.ru
Wagner, Vertex Pharmaceuticals evp, sells $4.39m in VRTX stock - Investing.com
Is Vertex Pharmaceuticals Incorporated stock positioned well for digital economyTrade Entry Report & Technical Confirmation Alerts - ulpravda.ru
Vertex Advances Suzetrigine Phase 3 Trial in Diabetic Nerve Pain, Signaling a Broader Growth Story - TipRanks
Weekly Recap: How Vertex Pharmaceuticals Incorporated stock performs in rising dollar environment2025 Institutional Moves & Technical Pattern Recognition Alerts - ulpravda.ru
RBC Raises Price Target on Vertex Pharmaceuticals to $455 From $415, Keeps Sector Perform Rating - MarketScreener
Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases - GlobeNewswire Inc.
Vertex Pharmaceuticals: The Cost Of Growing Beyond Cystic Fibrosis (Rating Downgrade) - Seeking Alpha
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 11 Analysts - Benzinga
‘We were sitting with our calculator saying “we can afford that!”’ Joy for families as cystic fibrosis drug prices fall within reach - The Guardian
Stocks making big moves yesterday: Herbalife, Vertex Pharmaceuticals, Micron, Amkor, and Palantir Technologies - The Globe and Mail
UBS Lowers Price Target for Vertex Pharmaceuticals (VRTX) to $53 - GuruFocus
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Stock Trades Up, Here Is Why - Finviz
Wolfe Research Upgrades Vertex Pharmaceuticals (VRTX) - Nasdaq
Wolfe Research Upgrades Vertex Pharmaceuticals (VRTX) to Outperf - GuruFocus
Vertex Pharmaceuticals (NASDAQ:VRTX) Upgraded to Outperform at Wolfe Research - MarketBeat
Wolfe Research Upgrades Vertex Pharmaceuticals to Outperform From Peer Perform, Price Target is $548 - MarketScreener
Robeco Institutional Asset Management B.V. Raises Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Advisory Resource Group Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings - Benzinga
5 Clinical Readouts to Watch in H1 2026 - BioSpace
Vertex Pharmaceuticals Incorporated $VRTX Position Increased by Asset Management One Co. Ltd. - MarketBeat
Aug Retail: Will Vertex Pharmaceuticals Incorporated VX1 stock test record highs in 2025Trade Volume Report & Verified Chart Pattern Signals - moha.gov.vn
Generali Asset Management SPA SGR Acquires 6,942 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Coastline Trust Co Sells 3,145 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Best Biotech Stocks To Follow NowJanuary 1st - MarketBeat
VIRGINIA RETIREMENT SYSTEMS ET Al Makes New Investment in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
The Best Stocks to Invest $1,000 in to Start the New Year Off Right - Finviz
When Phase 3 Data Drops, What Determines A Sustained Rally Vs. A Fading Initial Pop - Benzinga
25,734 Shares in Vertex Pharmaceuticals Incorporated $VRTX Bought by Generate Investment Management Ltd - MarketBeat
Ethic Inc. Has $5.47 Million Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals: Prepared To Defend Their Dominance And Expand Their Expertise - Seeking Alpha
Vertex Pharmaceuticals (VRTX) Dips More Than Broader Market: What You Should Know - sharewise.com
Vertex Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Momentum Stock - Nasdaq
2 Growth Stocks to Buy For 2026 and Beyond - Finviz
Analysts Are Bullish on These Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Edgewise Therapeutics (EWTX) - The Globe and Mail
Vertex Pharmaceuticals price target raised to $525 from $456 at Leerink - Yahoo Finance
Orna Therapeutics collaborates with Vertex Pharmaceuticals to develop approaches for sickle cell disease - MSN
Vertex Pharmaceuticals (VRTX) Target Price Raised to $525 by Lee - GuruFocus
Leerink Partners Boosts Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $525.00 - MarketBeat
Should You Be Confident in Vertex Pharmaceuticals Incorporated’s (VRTX) Long-Term Outlook? - Insider Monkey
Vertex Pharma’s Cystic Fibrosis Franchise: How Trikafta Powers the Pipeline — and the Stock - AD HOC NEWS
Biotech Stocks To Keep An Eye OnDecember 25th - MarketBeat
Burney Co. Reduces Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock: Biotech momentum meets Wall Street optimism - AD HOC NEWS
Forget Moderna Stock, This is a Much Better Buy - Finviz
Vertex Pharmaceuticals Earnings Notes - Trefis
Greenwood Capital Associates LLC Acquires 2,514 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Pacer Advisors Inc. Acquires 26,543 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Market Review: How analysts rate Vertex Pharmaceuticals Incorporated stock todayJuly 2025 Fed Impact & Long-Term Safe Investment Plans - moha.gov.vn
Is Vertex Pharmaceuticals Stock Underperforming the Nasdaq? - MSN
Exchange Traded Concepts LLC Purchases 7,565 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Shares Bought by Vontobel Holding Ltd. - MarketBeat
1.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):